WHO:Available evidence suggests no need to change the recommended influenza A/H5N1 vaccine prototype strains
submited by kickingbird at Jul, 20, 2005 21:9 PM from WHO
The WHO H5 Reference Laboratory Network and WHO Collaborating Centres and Reference Laboratories have reviewed available data to assess the suitability of the H5N1 prototype strains selected by WHO last year for influenza A/H5N1 pandemic vaccine development. The results of genetic and antigenic analyses of 2004 and 2005 human and animal A/H5N1 viruses received from affected countries, did not provide any convincing evidence to change the WHO recommended A/H5N1 influenza vaccine prototype strains. Therefore, the WHO recommendations from April 2004 are still valid.
WHO will continue to monitor the antigenic and genetic changes in circulating A/H5N1 viruses, especially in humans. For research purposes, the WHO Collaborating Centres will develop experimental prototype vaccine strains from recent human influenza A/H5N1 viruses.
The timely selection and verification of suitable H5N1 prototype vaccine strains depends primarily on close collaboration between the affected countries and WHO, especially as regards the rapid sharing of A/H5N1 virus/specimens, particularly from humans, and exchange of analytical data.
- Statement from the Public Health Agency of Canada: Update on Avian Influenza and Risk to Canadians 9 hours ago
- China: Human cases of avian influenza A(H9N2) reported in Hubei, Hunan, Jiangxi, Sichuan provinces 1 days ago
- Canada: First presumptive positive case of H5 avian influenza detected in B.C. 4 days ago
- WOAH: Japan - Influenza A viruses of high pathogenicity (Infection with H5N1)(non-poultry including wild birds) (2017-) 4 days ago
- WOAH: Korea (Rep. of) - High pathogenicity avian influenza viruses (poultry) (Infection with H5N3) - Immediate notification 4 days ago
[Go Top] [Close Window]